Literature DB >> 11800374

Instability of extracellular matrix gene expression in primary cell culture of fibroblasts from human vocal fold lamina propria and tracheal scar.

Susan L Thibeault1, Wenhua Li, Steven D Gray, Zhong Chen.   

Abstract

Primary fibroblast cell cultures were established from lamina propria of human vocal fold and tracheal scar. There exists a crucial need to provide new tools for studying voice biology, and one of the first steps is the development of a human primary laryngeal cell culture bank. Because cell lines can lose their differentiated phenotype in culture across passages, documentation of gene expression must be determined for passage populations, for us to have knowledge of cell behavior in vitro. Comparison of messenger RNA gene expression of extracellular matrix proteins (procollagen I, collagenase, elastin, hyaluronic acid synthase 2, hyaluronidase, fibronectin, cd44, fibromodulin, and decorin) across cell passages (3, 4, 5, 6, 10, and 12 fornormal laminapropria and 3, 4, 5, 6, and 10 for tracheal scar) revealed varied growth patterns. Cytogenetic analysis demonstrated relative stability of the karyotypes across passages for the tracheal scar cell cultures, whereas the karyotypes of the normal lamina propria fibroblasts showed instability in in vitro cultures. Recommendations for use of primary cell cultures for further studies of gene expression are made.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11800374     DOI: 10.1177/000348940211100102

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  15 in total

1.  In vivo comparison of biomimetic approaches for tissue regeneration of the scarred vocal fold.

Authors:  Susan L Thibeault; Sarah A Klemuk; Marshall E Smith; Cecilia Leugers; Glenn Prestwich
Journal:  Tissue Eng Part A       Date:  2009-07       Impact factor: 3.845

2.  Homeostasis of hyaluronic acid in normal and scarred vocal folds.

Authors:  Ichiro Tateya; Tomoko Tateya; Makoto Watanuki; Diane M Bless
Journal:  J Voice       Date:  2014-12-09       Impact factor: 2.009

3.  [Development and validation of the Chronic Otitis Media Outcome Test 15 (COMOT-15). Measurement of health-related quality of life in patients with chronic otitis media].

Authors:  I Baumann; B Kurpiers; P K Plinkert; M Praetorius
Journal:  HNO       Date:  2009-09       Impact factor: 1.284

4.  A method for identification of vocal fold lamina propria fibroblasts in culture.

Authors:  Susan L Thibeault; Wenhua Li; Stephanie Bartley
Journal:  Otolaryngol Head Neck Surg       Date:  2008-12       Impact factor: 3.497

5.  The human umbilical vein with Wharton's jelly as an allogeneic, acellular construct for vocal fold restoration.

Authors:  Roger W Chan; Maritza L Rodriguez; Peter S McFetridge
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

6.  Vocal fold myofibroblast profile of scarring.

Authors:  Anete Branco; Stephanie M Bartley; Suzanne N King; Marie E Jetté; Susan L Thibeault
Journal:  Laryngoscope       Date:  2015-09-07       Impact factor: 3.325

7.  Cell viability viscoelastic measurement in a rheometer used to stress and engineer tissues at low sonic frequencies.

Authors:  Sarah A Klemuk; Sanyukta Jaiswal; Ingo R Titze
Journal:  J Acoust Soc Am       Date:  2008-10       Impact factor: 2.482

8.  Effect of different factors on proliferation of antler cells, cultured in vitro.

Authors:  Erika Kužmová; Luděk Bartoš; Radim Kotrba; George A Bubenik
Journal:  PLoS One       Date:  2011-03-28       Impact factor: 3.240

Review 9.  Vocal aging and adductor spasmodic dysphonia: response to botulinum toxin injection.

Authors:  Michael P Cannito; Joel C Kahane; Lesya Chorna
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

10.  The CXC chemokine cCAF stimulates precocious deposition of ECM molecules by wound fibroblasts, accelerating development of granulation tissue.

Authors:  Jo Ellen Feugate; Lina Wong; Qi-Jing Li; Manuela Martins-Green
Journal:  BMC Cell Biol       Date:  2002-06-10       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.